This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, Université Grenoble Alpes. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2025
Title: Rémi Toutain: Innovator in Bacteriophage Sensitivity Determination
Introduction
Rémi Toutain is a notable inventor based in Grenoble, France. He has made significant contributions to the field of microbiology, particularly in the study of bacterial strains and their interactions with bacteriophages. His innovative approach has led to the development of a unique method that enhances our understanding of bacterial sensitivity.
Latest Patents
Rémi Toutain holds a patent for a method that determines the sensitivity of a bacterial strain to a bacteriophage. This method involves assessing the sensitivity of a bacterial strain of interest to a viral strain of bacteriophages. The patent represents a crucial advancement in microbiological research and has potential applications in various fields, including medicine and biotechnology.
Career Highlights
Throughout his career, Rémi Toutain has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Rémi has collaborated with talented individuals, including Prisca Perlemoine and Thomas Bordy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Rémi Toutain's contributions to the field of bacteriophage sensitivity determination highlight his role as an influential inventor. His work not only advances scientific knowledge but also opens new avenues for research and application in microbiology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile